Literature DB >> 11867070

Frontal lobe dysfunction in amyotrophic lateral sclerosis.

I Evdokimidis1, T S Constantinidis, P Gourtzelidis, N Smyrnis, I Zalonis, P V Zis, E Andreadou, C Papageorgiou.   

Abstract

The aim of the present study was to investigate the involvement of frontal lobe dysfunction in amyotrophic lateral sclerosis (ALS) using ocular motor paradigms and neuropsychological testing. Fifty-one patients with ALS participated in the following ocular motor tasks: (1) a three-choice task and (2) a remembered saccade task. The patients underwent a clinical and neuropsychological evaluation. One-third of ALS patients presented with signs of frontal dysfunction, as determined by their high distractibility factors (DF) in the three-choice task and their performances in both the Wisconsin and Stroop tests. ALS patients exhibited longer latencies to eye movement than controls in the performance of the remembered saccade task, specifically in performance of both remembered and delayed saccades, but saccade accuracy was not impaired. Finally, performance indices of the ocular motor tasks, in particular the DF, was correlated only with the degree of dysarthria.

Entities:  

Mesh:

Year:  2002        PMID: 11867070     DOI: 10.1016/s0022-510x(01)00683-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  Trail Making Test error analysis in classic motor neuron disease.

Authors:  Foteini Christidi; Evangelia Kararizou; Nikolaos I Triantafyllou; George P Paraskevas; Ioannis Zalonis
Journal:  Neurol Sci       Date:  2012-11-18       Impact factor: 3.307

2.  Slow saccades in bulbar-onset motor neurone disease.

Authors:  Colette Donaghy; Ralph Pinnock; Sharon Abrahams; Chris Cardwell; Orla Hardiman; Victor Patterson; R Canice McGivern; J Mark Gibson
Journal:  J Neurol       Date:  2010-02-10       Impact factor: 4.849

3.  Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.

Authors:  R R Rule; J Suhy; N Schuff; D F Gelinas; R G Miller; M W Weiner
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2004-09

4.  Eye Movement Abnormalities in Amyotrophic Lateral Sclerosis in a Tunisian Cohort.

Authors:  Arwa Rekik; Saloua Mrabet; Imen Kacem; Amina Nasri; Mouna Ben Djebara; Amina Gargouri; Riadh Gouider
Journal:  Neuroophthalmology       Date:  2022-03-02

5.  Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients.

Authors:  Herbert Schreiber; Tanja Gaigalat; Ursula Wiedemuth-Catrinescu; Michael Graf; Ingo Uttner; Rainer Muche; Albert Christian Ludolph
Journal:  J Neurol       Date:  2005-03-08       Impact factor: 4.849

6.  The use of P300-based BCIs in amyotrophic lateral sclerosis: from augmentative and alternative communication to cognitive assessment.

Authors:  Pietro Cipresso; Laura Carelli; Federica Solca; Daniela Meazzi; Paolo Meriggi; Barbara Poletti; Dorothée Lulé; Albert C Ludolph; Vincenzo Silani; Giuseppe Riva
Journal:  Brain Behav       Date:  2012-07       Impact factor: 2.708

7.  Motor neuronopathy with dropped hands and downbeat nystagmus: a distinctive disorder? A case report.

Authors:  Nimish J Thakore; Erik P Pioro; Janet C Rucker; R John Leigh
Journal:  BMC Neurol       Date:  2006-01-12       Impact factor: 2.474

8.  Detection of residual cognitive function through non-spontaneous eye movement in a patient with advanced frontotemporal dementia.

Authors:  Akira Midorikawa; Chihiro Itoi; Mitsuru Kawamura
Journal:  Front Neurosci       Date:  2014-10-24       Impact factor: 4.677

9.  Eye-tracking in amyotrophic lateral sclerosis: A longitudinal study of saccadic and cognitive tasks.

Authors:  Malcolm Proudfoot; Ricarda A L Menke; Rakesh Sharma; Claire M Berna; Stephen L Hicks; Christopher Kennard; Kevin Talbot; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-08-27       Impact factor: 4.092

10.  A neurostimulant para-chloroamphetamine inhibits the arginylation branch of the N-end rule pathway.

Authors:  Yanxialei Jiang; Won Hoon Choi; Jung Hoon Lee; Dong Hoon Han; Ji Hyeon Kim; Young-Shin Chung; Se Hyun Kim; Min Jae Lee
Journal:  Sci Rep       Date:  2014-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.